rbmc,
The reason I ended up getting doxorubicin instead of mitomycin is a shortage of mitomycin, something I confirmed later is documented in news reports and on the web site of the FDA. As a result, my hospital isn't making it available for perisurgical intravesical chemotherapy. I wasn't thrilled to have this explained to me after the surgery, but my doctor said that studies have not shown any statistically significant differences in efficacy. I thought I vaguely remembered reading that before, but I'll go check now. Assuming it's true, that's still not how I want these choices made if I can help it. Doxorubicin has also been in short supply at times and is (again according to the doctor) more expensive than mitomycin. So in a way, he said, I'm lucky because I got to receive the more expensive drug. More proof, if proof were needed, that doctors don't understand copayments at all.
I realize this post is a bit more jaded than the first, which was written in the PACU. Surviving surgery makes me euphoric! And I am still mighty happy.
PST